NUBORN MEDICAL INC

Saint Paul, MN · Medtech · Private

Smart bottle device that non-invasively detects neonatal swallowing deficits through objective sensor-based measurement

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
Saint Paul, MN
Total capital
$2.1M
Federal grants
$2.1M
4 awards · 2020–2025
Rank in peer group#198 of 542
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
first 2023
Rank in peer group#106 of 542

Capital timeline

202020212022202320242025FEDERAL ↑EQUITY ↓Cumulative $2.1M$256K$256K$859K$761K
202020212022202320242025FEDERAL ↑EQUITY ↓Cumulative $2.1M$256K$256K$859K$761K

Latest events

  • Federal grantHealth and Human S · Phase II · A Novel Non-Invasive Method of Dysphagia Detection in Preterm Infants: Bottle Finalization & Validation$761K
  • Federal grantHealth and Human S · Phase II · A Novel Non-Invasive Method of Dysphagia Detection in Preterm Infants: Bottle Finalization & Validation$859K
  • Federal grantHealth and Human S · Phase I · A novel non-invasive method of aspiration detection in preterm infants.$256K
  • Federal grantHealth and Human S · Phase I · A novel non-invasive method of aspiration detection in preterm infants.$256K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 542 peers

Line = median

Medtech · Device

  • Federal grants#198 · top 37%
  • Granted patents#106 · top 20%
  • Linked publications#5 · top 1%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 1

Recent research by its founders

  • Swallowing and feeding after disease-modifying treatment for spinal muscular atrophy: a systematic review of assessment modalities and outcomes20263 cites
  • Additional file 1 of Swallowing and feeding after disease-modifying treatment for spinal muscular atrophy: a systematic review of assessment modalities and outcomes20260 cites
  • Swallowing and Communication in Cockayne Syndrome: Clinical Characteristics and Management20260 cites

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .